Orthopedics This Week—May 26, 2017
Orthopedics This Week featured a study done by adult reconstruction and joint replacement surgeon, Alexander S. McLawhorn, MD, MBA. The study stated that dual mobility total hip replacements reduce cost as well as risk of dislocation.
"Dual mobility total hip replacements, which became FDA approved within the last decade, reduce the risk of dislocation, and they are being used with increasing frequency for primary total hip replacements in the United States," said Dr. McLawhorn.
Dr. McLawhorn compared the cost of total hip dislocations to the health care system, and added "because complications from dual mobility bearings appear to be quite low, dual mobility implants appear to be cost effective, even cost saving, in our exploratory model."
Read the full article at ryortho.com